| HCM | DCM | p |
---|---|---|---|
Sample number | 10 | 10 | Â |
Mean age (years) | 39 ± 14 | 47 ± 14 | 0.23 |
Male sex (%) | 80% | 80% | 1 |
BMI (kg/m2) | 22 ± 4.31 | 20 ± 1.51 | 0.26 |
UCG | Â | Â | Â |
 LVEF (%) | 30.29 ± 10.42 | 25 ± 6.37 | 0.21 |
 LVEDD (mm) | 61.6 ± 14.04 | 68.6 ± 7.98 | 0.21 |
 IVS (mm) | 13.98 ± 3.16 | 8.9 ± 1.36 | 0.001** |
 LVPW (mm) | 10.48 ± 3.33 | 8.6 ± 1.28 | 0.141 |
Comorbidities | |||
 Hypertension | 20% (2) | 0 | 0.151 |
 Ventricular tachycardia | 40% (4) | 40% (4) | 1 |
 Diabetes | 10% (1) | 50% (5) | 0.054 |
 Myocardial infarction | 0 | 0 | 1 |
 Atrial fibrillation | 40% (4) | 50% (5) | 0.673 |
Medications | Â | Â | Â |
 Digoxin | 50% (5) | 70% (7) | 0.388 |
 β-blocker | 80% (8) | 40% (4) | 0.074 |
 Aldosterone antagonist | 70% (7) | 50% (5) | 0.388 |
 ACE inhibitor/ARB | 20% (2) | 20% (2) | 1 |
Mean heart weight (g) | 542.1 ± 144.88 | 380.9 ± 61.01 | 0.01* |